ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing

By: via Benzinga
ImmunoGen Inc(NASDAQ: IMGN) announced a global, multi-targetlicense and option agreementthat grantedVertex ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.